Self-Reported Postpartum Depressive Symptoms Up During Pandemic

THURSDAY, May 12, 2022 (HealthDay News) -- There was a national increase in postpartum depressive symptoms (PDS) that worsened over the course of a year following the start of the COVID-19 pandemic, according to a study published in the July issue of the Journal of Psychiatric Research.
Mira A. Bajaj, from the Johns Hopkins School of Medicine in Baltimore, and colleagues assessed changes in PDS during the COVID-19 pandemic. The analysis included responses from users of the Flo mobile health application who completed a survey about their mood within 90 days of giving birth (prepandemic: 159,478 women; pandemic period: 118,622 women).
The researchers found that U.S. national rates of PDS increased from 6.5 percent prepandemic to 6.9 percent during the pandemic, with significant worsening during the first year of the pandemic. There was a negative association between percent change in PDS across states and both COVID-19 deaths per 100,000 residents and the 2020 unemployment rate for women. Changes in PDS were not associated with COVID-19 cases per 100,000 residents, percent job loss, percent change in women's unemployment rate, or the percentage of population staying at home.
"There are several possible explanations for this pattern of state-level findings," the authors write. "One possibility is that in states where there was a higher death toll or women's unemployment rate, families spent more time together and the new mothers had greater access to their support systems."
Two authors disclosed financial ties to Flo Health.
Related Posts
La telesalud, que se usó durante la pandemia, redujo las sobredosis de opioides
VIERNES, 2 de septiembre de 2022 (HealthDay News) -- La telesalud floreció...
El aire contaminado de las ciudades mató a más de 1.8 millones de personas en todo el mundo en 2019
JUEVES, 6 de enero de 2022 (HealthDay News) -- Las ciudades de todo el mundo...
Cigarette Smoking Down for Adults With Behavioral Health Conditions
FRIDAY, April 29, 2022 (HealthDay News) -- There were significant reductions in...
Many Receiving Alpelisib for Metastatic Breast Cancer Have Hyperglycemia
MONDAY, Sept. 25, 2023 (HealthDay News) -- For patients with metastatic breast...
